Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
State Policy
D.C. Detailer Law Provides New Definition of 30 Consecutive Days
We have previously written about the change in the Washington, D.C. pharmaceutical detailer license requirements. The…
Pricing Bills Are Popping Up Everywhere – Review of State Prescription Drug…
The price of prescription drugs has created much controversy in recent years. This article examines why the…
Vermont Governor Signs Drug Price Transparency Bill
On Friday, June 3, 2016, Vermont Governor Peter Shumlin signed into law a bill that aims to require greater transparency on behalf…
Shatterproof Report on Critical Elements of Effective State Opioid…
The opioid epidemic has been a prominent talking point in many circles lately, including physician groups, Congress,…
Massachusetts Cost Trend Report and Suggestions
Massachusetts is required to release annual Cost Trend reports that make recommendations and commitments to advance…
Vermont: First State to Pass Pharmaceutical Cost Transparency Bill
Vermont is soon to be the first state in the nation that requires pharmaceutical manufacturers to explain the reasons…
Washington State Convenes Task Force on Drug Prices
"Don't stop trying" that is the theme of the Washington State legislature as overrode a governor's veto to push through…
District of Columbia Makes Changes Transparency Law to Align with Open…
Late last week with only a photo attachment, the District of Columbia Department of Health announced to the…
Massachusetts Medical Society Requires Social Media Disclosure by…
The idea that doctors are promoting treatments on social media has gotten some attention from media outlets over the…
Endo New York Settlement Announcement
New York Attorney General Eric T. Schneiderman announced an agreement with Endo Health Solutions, Inc. and Endo…